Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -109,224 | -124,534 | -153,204 | -237,573 | -143,166 |
| Depreciation Amortization | 11,562 | 13,097 | 14,933 | 14,645 | 8,931 |
| Income taxes - deferred | N/A | N/A | -627 | 534 | N/A |
| Accounts receivable | 2,878 | -1,931 | 430 | 61 | -1,591 |
| Other Working Capital | -1,282 | 37,872 | -29,356 | 18,518 | -2,096 |
| Other Operating Activity | 17,809 | 23,181 | 11,899 | 12,376 | 9,774 |
| Operating Cash Flow | $-78,257 | $-52,315 | $-155,925 | $-191,439 | $-128,148 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 20,433 | 16,263 | -25,900 | 4,994 |
| PPE Investments | -586 | -4,164 | -5,068 | -42,752 | -17,402 |
| Other Investing Activity | -86 | 48 | 170 | 179 | -188 |
| Investing Cash Flow | $-672 | $16,317 | $11,365 | $-68,473 | $-12,596 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 111,865 | 1,000 | 48,455 |
| Debt Repayment | -998 | -717 | -581 | -240 | -481 |
| Common Stock Issued | 17,977 | 120,466 | 65,368 | 1,733 | 106,736 |
| Other Financing Activity | -31,137 | -30,000 | -10,000 | -55,834 | 0 |
| Financing Cash Flow | $-14,158 | $89,749 | $166,652 | $-53,341 | $154,710 |
| Exchange Rate Effect | 50 | 2,185 | -688 | -407 | -21 |
| Beginning Cash Position | 150,669 | 94,733 | 73,329 | 386,989 | 373,044 |
| End Cash Position | 57,632 | 150,669 | 94,733 | 73,329 | 386,989 |
| Net Cash Flow | $-93,037 | $55,936 | $21,404 | $-313,660 | $13,945 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,257 | -52,315 | -155,925 | -191,439 | -128,148 |
| Capital Expenditure | -619 | -4,211 | -5,331 | -42,790 | -17,423 |
| Free Cash Flow | -78,876 | -56,526 | -161,256 | -234,229 | -145,571 |